March 2019 Awareness Night Prostate Cancer Genetics: Where are we now? Justin Lorentz MSc, CGC Cancer Genetic Counsellor Lead,Male Oncology Research and Education (MORE) Dept of Radiation Oncology, Sunnybrook Odette Cancer Centre CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 41:24 minutes
BRCA1 and BRCA2 are human genes that produce tumor suppressor proteins. Men with harmful BRCA1 or BRCA2 mutations have a higher risk of prostate cancer. A Toronto Women’s College Hospital research study, The Screen Project, provides Canadians access to affordable population-based genetic testing for the BRCA gene mutation. Watch the video here.
Leading American and British cancer researchers are urging that all men with advanced prostate cancer strongly consider being tested for inherited gene mutations — both to help steer their treatment and to alert family members who themselves might be at increased risk for a range of cancers. Read the article here.